EE05272B1 - Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine - Google Patents

Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Info

Publication number
EE05272B1
EE05272B1 EEP200300500A EEP200300500A EE05272B1 EE 05272 B1 EE05272 B1 EE 05272B1 EE P200300500 A EEP200300500 A EE P200300500A EE P200300500 A EEP200300500 A EE P200300500A EE 05272 B1 EE05272 B1 EE 05272B1
Authority
EE
Estonia
Prior art keywords
compounds
derivatives
mercaptoacetamide
preparation
disclosed
Prior art date
Application number
EEP200300500A
Other languages
English (en)
Estonian (et)
Inventor
A. Flynn Gary
Mehdi Shujaath
Roger Koehl Jack
Ann Anderson Barbara
Gerken Manfred
Jablonka Bernd
Kleemann Heinz-Werner
Linz Wolfgang
Seiz Werner
Seuring Bernhard
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of EE200300500A publication Critical patent/EE200300500A/xx
Publication of EE05272B1 publication Critical patent/EE05272B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EEP200300500A 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine EE05272B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Publications (2)

Publication Number Publication Date
EE200300500A EE200300500A (et) 2003-12-15
EE05272B1 true EE05272B1 (et) 2010-02-15

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300500A EE05272B1 (et) 2001-04-12 2002-04-03 Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine

Country Status (27)

Country Link
EP (1) EP1381605B1 (zh)
JP (1) JP4392167B2 (zh)
CN (1) CN1245404C (zh)
AT (1) ATE286898T1 (zh)
AU (1) AU2002304804B2 (zh)
BG (1) BG66387B1 (zh)
BR (1) BR0208889A (zh)
CA (1) CA2443488C (zh)
CZ (1) CZ299708B6 (zh)
DE (1) DE60202602T2 (zh)
EE (1) EE05272B1 (zh)
ES (1) ES2232752T3 (zh)
HK (1) HK1061690A1 (zh)
HR (1) HRP20030823B1 (zh)
HU (1) HU229612B1 (zh)
IL (1) IL158289A0 (zh)
MA (1) MA26098A1 (zh)
MX (1) MXPA03008613A (zh)
NO (1) NO325655B1 (zh)
NZ (1) NZ528825A (zh)
OA (1) OA12502A (zh)
PL (1) PL209338B1 (zh)
PT (1) PT1381605E (zh)
RU (1) RU2286346C2 (zh)
SI (1) SI1381605T1 (zh)
SK (1) SK287616B6 (zh)
WO (1) WO2002083671A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
ATE155143T1 (de) * 1991-09-27 1997-07-15 Merrell Pharma Inc 2-substituierte indan-2-mercaptoacetylamid- verbindungen mit enkephalinase und ace- hemmwirkung
CA2140553A1 (en) * 1993-06-11 1994-12-22 Hitoshi Oinuma Amino acid derivative

Also Published As

Publication number Publication date
CN1501926A (zh) 2004-06-02
CZ299708B6 (cs) 2008-10-29
SI1381605T1 (en) 2005-06-30
BG66387B1 (bg) 2013-11-29
HUP0303482A2 (hu) 2004-01-28
DE60202602T2 (de) 2006-03-23
BG108203A (bg) 2004-12-30
BR0208889A (pt) 2004-06-29
CN1245404C (zh) 2006-03-15
HRP20030823B1 (en) 2011-10-31
WO2002083671A1 (en) 2002-10-24
EE200300500A (et) 2003-12-15
NZ528825A (en) 2005-04-29
JP2004525966A (ja) 2004-08-26
CA2443488A1 (en) 2002-10-24
PL209338B1 (pl) 2011-08-31
MXPA03008613A (es) 2003-12-08
PL363034A1 (en) 2004-11-15
SK12552003A3 (sk) 2004-03-02
HU229612B1 (en) 2014-03-28
OA12502A (fr) 2006-05-29
ATE286898T1 (de) 2005-01-15
DE60202602D1 (de) 2005-02-17
CZ20032722A3 (cs) 2004-01-14
PT1381605E (pt) 2005-03-31
NO20034412L (no) 2003-10-02
CA2443488C (en) 2011-05-31
RU2003132875A (ru) 2005-03-20
EP1381605A1 (en) 2004-01-21
NO325655B1 (no) 2008-06-30
MA26098A1 (fr) 2004-04-01
IL158289A0 (en) 2004-05-12
AU2002304804B2 (en) 2007-05-10
HRP20030823A2 (en) 2005-08-31
EP1381605B1 (en) 2005-01-12
ES2232752T3 (es) 2005-06-01
JP4392167B2 (ja) 2009-12-24
HK1061690A1 (en) 2004-09-30
SK287616B6 (sk) 2011-04-05
HUP0303482A3 (en) 2012-12-28
RU2286346C2 (ru) 2006-10-27
NO20034412D0 (no) 2003-10-02

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
WO2002100845A8 (en) Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
WO2003082857A3 (en) Lansoprazole polymorphs and processes for preparation thereof
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
HK1111168A1 (en) A PROCESS FOR THE PREPARATION OF 17-HYDROXY-6 ß,7ß,15 ß,16 ß - BISMETHYLENE-17a-PREGN-4-ENE-3-ONE-21-CARBOXYLIC ACID Y-LACTONE AND KEY-INTERMEDIATES FOR THIS PROCESS
WO2004012663A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
WO2004050663A3 (en) An improved process for the preparation of cefuroxime sodium
CY1109950T1 (el) Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν
SG165159A1 (en) Process for preparing 6-alkylidene penem derivatives
DE60015508T2 (de) C-16 ungesätigte fp-selektive prostaglandin analoge
EE05272B1 (et) Merkaptoatsetlamiidi derivaadid, nende valmistamismeetod ja kasutamine
AU2002357740A1 (en) Pyrazolo-pyridine derivatives as antiherpes agents
WO2003028645A3 (en) Novel compositions of carvedilol
WO2002085877A3 (en) Processes and intermediates for preparing benzyl substituted epoxides
MXPA05003881A (es) Preparacion de compuestos triazospiro.
WO2002010124A3 (en) Salt forms of an hiv protease inhibitor
ATE328883T1 (de) Imidazopyridin-8-one
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
WO2002083641A3 (en) Amino-aza-cyclohexanes for the treatment of malaria
MXPA04001846A (es) Indan-1-onas c2-substituidas y sus derivados, metodos para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160403